ClinicalTrials.gg
Not yet recruitingNCT06627829Updated Oct 4, 2024

Effect of Different Grafting Material Following Surgically Facilitated Orthodontics Therapy

An interventional study of Surgically facilitated orthodontics therapy (SFOT) using allograft and Surgically facilitated orthodontics therapy (SFOT) using xenograft in Malocclusion, Angle Class I, sponsored by The University of Texas Health Science Center, Houston. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-10-04.

Sponsored by The University of Texas Health Science Center, Houston · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Jan 2026, 10 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to quantitatively investigate the radiographic changes of alveolar bone, and gingival tissue changes of the mandibular anterior teeth in experimental group A receiving SFOT using freeze-dried allograft with a collagen membrane, experimental group B receiving SFOT using particulate xenograft covered by a collagen membrane and control group receiving only orthodontics therapy.

02

Conditions studied

  • Malocclusion, Angle Class I

Keywords

  • orthodontic treatment
03

In context

Malocclusion, Angle Class I

35 studies on the registry are indexed under Malocclusion, Angle Class I; 10 are open to participants now.

This study's planned enrollment of 24 is below the median of 32 across 31 interventional studies indexed under Malocclusion, Angle Class I.

Browse Malocclusion, Angle Class I studies →

Lead sponsor

The University of Texas Health Science Center, Houston is the lead sponsor of 897 studies on the registry; 214 are open to participants now.

Of its 173 completed or terminated interventional studies of FDA-regulated products, 142 (82%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • (ASA) I/II
  • Periodontal diagnosis of clinical gingival health or gingivitis on intact/reduced periodontium per 2017 American Academy of Periodontology (AAP) classification
  • No history of periodontitis.
  • Class I malocclusion
  • Crowding of 4 mm or less on mandibular anterior incisors
  • Incisor mandibular plane angle between 90-100 degrees
  • No extractions indicated as part of the orthodontic treatment plan
  • Keratinized tissue of at least 3mm

Exclusion criteria

Exclusion Criteria:

  • Patients who are current smokers
  • Pregnancy
  • Uncontrolled diabetes or other metabolic systemic conditions
  • Presence of open bite or deep bite
  • Spacing
  • Excessive retroclined mandibular incisors
  • Any to treatment or the material used if in the experimental groups
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
24 participants (estimated)

Study arms

  • Experimental
    Group A

    Device: Surgically facilitated orthodontics therapy (SFOT) using allograft

  • Experimental
    Group B

    Device: Surgically facilitated orthodontics therapy (SFOT) using xenograft

  • Active comparator
    Control group

    Device: Usual care

Interventions

  • DeviceSurgically facilitated orthodontics therapy (SFOT) using allograft

    Participants will receive Surgically facilitated orthodontics therapy (SFOT) along with bone grafting using particulate allograft and collagen membrane, prior to orthodontics treatment.

  • DeviceSurgically facilitated orthodontics therapy (SFOT) using xenograft

    Participants will receive SFOT using particulate xenograft and collagen membrane, prior to orthodontics treatment.

  • DeviceUsual care

    Participants will have conventional orthodontics treatment with Invisalign aligners, without any surgical intervention

06

What researchers measure

Primary outcomes

  1. Change in horizontal bone thickness at the 3mm point from Cementoenamel junction (CEJ) (crestal level) on the mandibular incisors

    Time frame: from baseline to endpoint (Alignment visit, approximately 4 months after the start of orthodontics treatment)

  2. Change in horizontal bone thickness at the 6mm point from CEJ (middle level) on the mandibular incisors

    Time frame: from baseline to endpoint (Alignment visit, approximately 4 months after the start of orthodontics treatment)

  3. Change in horizontal bone thickness at the 9mm point from CEJ (apical level) on the mandibular incisors

    Time frame: from baseline to endpoint (Alignment visit, approximately 4 months after the start of orthodontics treatment)

  4. Change in volume of three dimensional bone

    Time frame: from baseline to endpoint (Alignment visit, approximately 4 months after the start of orthodontics treatment)

  5. Change in volume of three dimensional soft tissue

    Time frame: from baseline to endpoint (Alignment visit, approximately 4 months after the start of orthodontics treatment)

Secondary outcomes

  1. Change in vertical bone level (VBL)from the CEJ

    Time frame: Baseline, at alignment (approximately 4 months after the start of orthodontics treatment).

  2. Change in probing depth (PD)

    PD is the distance from CEJ to base of gingival pocket

    Time frame: Baseline, at alignment (approximately 4 months after the start of orthodontics treatment).

  3. Change in clinical attachment level (CAL)

    CAL is the distance between CEJ and base of the pocket

    Time frame: Baseline, at alignment (approximately 4 months after the start of orthodontics treatment).

  4. Change in width of keratinized tissue (WKT) at alignment

    Time frame: Baseline, at alignment (approximately 4 months after the start of orthodontics treatment).

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2025; primary completion for Jan 2026, 12 months later.

Of 23 interventional studies with no phase under Malocclusion, Angle Class I, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 24. This study's planned 12 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 2, 2024
First posted
Oct 4, 2024
StartEst.
Jan 6, 2025
Primary completionEst.
Jan 6, 2026
CompletionEst.
Jan 6, 2027
Last update
Oct 4, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 4, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06627829
Collaborators
American Academy of Periodontology Foundation
Responsible party
Sahar Dowlatshahi (Assistant Professor, The University of Texas Health Science Center, Houston) — Principal investigator
First posted
Oct 4, 2024
Start date
Jan 6, 2025 (estimated)
Primary completion
Jan 6, 2026 (estimated)
Completion
Jan 6, 2027 (estimated)
Last update
Oct 4, 2024

Study contacts

Sahar Dowlatshahi, DDS, MMSc
Contact
Sahar.Dowlatshahi@uth.tmc.edu
(713) 486-4074
Nikola Angelov
Contact
Nikola.Angelov@uth.tmc.edu
(713) 486-4073
Sahar Dowlatshahi, DDS, MMSc
principal investigator · The University of Texas Health Science Center, Houston

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion